Blog

10 November, 2025

“Distefar, highly conscious of the environment, welcomes and echoes the environmental transformation that the pharmaceutical industry is undergoing towards sustainability.”

The goal of net zero emissions is a global commitment shared by many industries, including pharmaceuticals. However, the path to true sustainability goes beyond simple regulatory […]
5 November, 2025

The smart medicine revolution is reshaping the global pharmaceutical market

Advances in nanotechnology, biosensors, and artificial intelligence are redefining drug delivery, with a growing impact on therapeutic efficacy, patient adherence, and global pharmaceutical development. Consalud.es For […]
30 October, 2025

A study of stem cells opens the door to regenerating the brain after a stroke

A team from the University of Zurich demonstrates in mice that neural stem cell transplantation regenerates neurons, restores motor functions and opens up a path of […]
29 October, 2025

US tariffs threaten European pharmaceutical industry: its value could fall by up to 5%

A SUERF report warns that the tariffs imposed by Washington in 2025 will particularly affect the pharmaceutical sector in Europe, hitting countries such as Ireland, Belgium […]
27 October, 2025

Global Clinical Trials Forum: ‘Only those that are ethical, high-quality and inclusive will thrive’

The World Health Organisation explains in an interview with ConSalud.es that the recently launched Global Clinical Trials Forum seeks to combat fragmentation and barriers in research. […]
21 October, 2025

The geopolitical context presents Spain with a great opportunity to attract investment in the biopharmaceutical sector.

A new report by Analistas Financieros Internacionales (AFi) highlights the sector’s potential to become a global hub for innovation and drug production. Farmaindustria has presented seven […]
14 October, 2025

“Spain has a great opportunity in the biopharmaceutical sector, but it must review its policies to maintain and increase its potential and attract investment in R&D and in industrial and digital assets.”

The president of Farmaindustria, Fina Lladós, calls for a regulatory framework that improves the country’s competitiveness in order to turn the current situation of global uncertainty […]
7 October, 2025

Spain consolidates its leadership in clinical trials with new guidelines promoting innovation, digitalisation and sustainability in hospital pharmacy

Pharmacists and industry present the updated “Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy” in Barcelona. This is another step towards excellence and improving […]
2 October, 2025

Innovation and data at the service of clinical research

Our Director of Clinical and Translational Research, Amelia Martín Uranga, participated on Wednesday in Innodata 2025, a national conference on innovation through the use of health […]
30 September, 2025

Spain, European leader in clinical trials against cancer thanks to the agility and ‘atomisation’ of research groups

20minutos.es Spain is bucking the general decline in cancer clinical trials seen across Europe: it is the only country maintaining its level of research, compared to […]
24 September, 2025

Advanced therapies in lymphoma: six years of CAR-T that have changed patients’ lives

Gilead held the 6th Advanced Therapies Meeting to celebrate therapeutic advances in the treatment of lymphoma. consalud.es Advanced therapies are transforming the way we understand and […]
17 September, 2025

The Community of Madrid aspires to become the “Silicon Valley” of the pharmaceutical sector.

Madrid launches a pioneering strategy to become a global benchmark in biopharmaceutical innovation. consalud.es On Monday, the Community of Madrid presented its 2025-2028 Sector Strategy to […]
16 September, 2025

Farmaindustria welcomes the announcement by the Spanish Agency for Medicines and Health Products (AEMPS) to expand the accelerated assessment of early-stage clinical trials, as this strengthens the Spanish biomedical research ecosystem.

This “fast track” is one of the sector’s strategic measures in the field of biomedical research and is included in the National Pharmaceutical Industry Strategy. Patients […]
15 September, 2025

Australia’s recipe for strengthening medical research capacity and leading the way into the next decade

At a time of great challenges in global health research, one of the countries with the most influence in this field is preparing a national strategy […]
28 July, 2025

Study identifies proteins involved in the efficacy of immunotherapy against blood cancer

A recent study by the Centre for Cell Therapy (CTC) reveals proteins and signalling pathways that are crucial to the effectiveness of CAR-T cells, opening up […]
25 June, 2025

ISCIII and Farmaindustria sign an agreement to promote biomedical and healthcare research in Spain

The director of the ISCIII, Marina Pollán, and the president of Farmaindustria, Fina Lladós, have signed a General Action Protocol to promote research, innovation and knowledge […]
27 May, 2025

R&D investment by innovative pharmaceutical companies to exceed 1.5 billion euros by 2024

The Pharmaceutical R&D Survey 2024 reflects a steady increase in investment in clinical research over the last decade, which has grown at 7% per year. Direct […]
23 May, 2025

An appropriate regulatory framework and more impetus for innovation, key to increasing competitiveness in biomedical research

The XVIII Conference of Biomedical Research Technology Platforms brings together in Madrid more than 200 representatives from public administrations, regulatory agencies, universities and companies to analyse […]
22 May, 2025

Review of pharmaceutical legislation, the key opportunity to relaunch U.S. competitiveness

Nathalie Moll (EFPIA) warns in an interview with Health35 that the lack of regulatory consistency and proposed environmental changes threaten investment in biomedical R&D in Europe. […]
21 May, 2025

Spanish hospitals, at the forefront of clinical research in Europe

In order to host the studies, the centres must have the resources and infrastructure. Gregorio Marañón, La Paz, Clínic de Barcelona and Vall d’Hebron are some […]
13 May, 2025

Farmaindustria presents improvements to the Medicines Bill to prepare healthcare for innovation over the next 20 years

Farmaindustria presents improvements to the Draft Medicines Bill to prepare healthcare for innovation in the next 20 yearsThe future law should promote greater investment in healthcare, […]
12 May, 2025

Fina Lladós: ‘We have before us a unique opportunity in these legislative developments to transform our healthcare and prepare it for the next 20 years’.

“It is essential to see medicines and healthcare as an economically and socially very profitable investment for Spain. An investment that generates very important benefits in […]
8 May, 2025

Spain, a European success story in clinical trials of new drugs

eleconomista.es In 2023, Spain overtook Germany as the country that initiated the most clinical trials and became the European leader. This is reflected in the report […]
22 April, 2025

Joint position on the draft Medicines and Medical Devices Law

Joint position on the Draft Bill on Medicines and Health ProductsThe proposed system of price regulation for off-patent medicines puts at risk the supply of medicines […]
8 April, 2025

The global pharmaceutical industry had 12,700 drugs in development by 2024

The International Federation of Innovative Pharmaceutical Industries indicates that the sector invests almost 30% of its revenues in R&D, amounting to nearly 270 billion euros. Diarofarma.com […]
18 March, 2025

Regional health officials and Farmaindustria meet to analyse new pharmaceutical regulations, the proper use of medicines and advances in digital health

The Regional Minister of Health of Cantabria, César Pascual, inaugurates the 25th CAAC-Pharmaindustry Forum. ‘When we work together, not only do we promote research and biomedical […]
6 March, 2025

Spain has more than 1,050 clinical trials for rare diseases underway and nine out of ten are promoted by the pharmaceutical industry.

This research momentum means that one in three new medicines approved by Europe in 2024 was classified as an orphan drug. There are still many untreated […]
4 March, 2025

Distefar has been present at the European Clinical Trial Supply and Temperature controlled logistics in Biopharmaceuticals 2025, on 25th and 26th of February.

Getting to know new markets and establishing contacts with both potential customers and potential suppliers. Temperature control in pharmaceutical logistics is one of our pillars, as […]
20 February, 2025

The pharmaceutical industry is committed to Spain with investments of 9,000 million euros and asks the Prime Minister to continue supporting legislative reforms that favour innovation, strategic autonomy and predictability.

The President of the Government meets for the second time with around twenty representatives of the national, European and global pharmaceutical industry to intensify public-private collaboration […]
13 February, 2025

The pharmaceutical industry generates more than 27 billion euros of added value in Spain, almost 2% of the country’s GDP.

For the first time, a study by the consultancy firm Afi has evaluated the impact of pharmaceutical companies from a dual perspective: the socio-economic value provided […]
28 January, 2020

Clinical trials, cost savings for the system and innovative therapies for the patient

They are essential to demonstrate the safety of medicines, but they also represent a significant cost savings in the health centers where they are carried out. […]